Epigenetics and cardiovascular disease (original) (raw)

• Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442 (2006).
  PubMed PubMed Central Google Scholar
• MacKinnon, A. U. The origin of the modern epidemic of coronary artery disease in England. J. R. Coll. Gen. Pract. 37, 174–176 (1987).
  CAS PubMed PubMed Central Google Scholar
• Azambuja, M. I. & Levins, R. Coronary heart disease (CHD)-—one or several diseases? Changes in the prevalence and features of CHD. Perspect. Biol. Med. 50, 228–242 (2007).
  PubMed Google Scholar
• Dawber, T. R., Meadors, G. F. & Moore, F. E. Jr. Epidemiological approaches to heart disease: the Framingham Study. Am. J. Public Health Nations Health 41, 279–281 (1951).
  CAS PubMed PubMed Central Google Scholar
• Gersh, B. J., Sliwa, K., Mayosi, B. M. & Yusuf, S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur. Heart J. 31, 642–648 (2010).
  PubMed Google Scholar
• Grundy, S. M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239 (2004).
  PubMed Google Scholar
• Sabatti, C. et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 41, 35–46 (2009).
  CAS PubMed Google Scholar
• Sipido, K. R. et al. Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc. Res. 83, 425–435 (2009).
  CAS PubMed Google Scholar
• Omics.org Alphabetically ordered list of omes and omics [online], (2009).
• Turan, N., Katari, S., Coutifaris, C. & Sapienza, C. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics 5, 16–19 (2010).
  CAS PubMed Google Scholar
• Wierda, R. J., Geutskens, S. B., Jukema, J. W., Quax, P. H. & van den Elsen, P. J. Epigenetics in atherosclerosis and inflammation. J. Cell. Mol. Med. doi:10.1111/j.1582-4934201001022.x.
• Turunen, M. P., Aavik, E. & Ylä-Herttuala, S. Epigenetics and atherosclerosis. Biochim. Biophys. Acta 1790, 886–891 (2009).
  CAS PubMed Google Scholar
• Gluckman, P. D., Hanson, M. A., Buklijas, T., Low, F. M. & Beedle, A. S. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 5, 401–408 (2009).
  CAS PubMed Google Scholar
• Krause, B., Sobrevia, L. & Casanello, P. Epigenetics: new concepts of old phenomena in vascular physiology. Curr. Vasc. Pharmacol. 7, 513–520 (2009).
  CAS PubMed Google Scholar
• Ling, C. & Groop, L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58, 2718–2725 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mack, C. P. An epigenetic clue to diabetic vascular disease. Circ. Res. 103, 568–570 (2008).
  CAS PubMed PubMed Central Google Scholar
• Stöger, R. Epigenetics and obesity. Pharmacogenomics 9, 1851–1860 (2008).
  PubMed Google Scholar
• Gluckman, P. D. & Hanson, M. A. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int. J. Obes. 32 (Suppl. 7), S62–S71 (2008).
  CAS Google Scholar
• Campión, J., Milagro, F. I. & Martínez, J. A. Individuality and epigenetics in obesity. Obes. Rev. 10, 383–392 (2009).
  PubMed Google Scholar
• Dong, C., Yoon, W. & Goldschmidt-Clermont, P. J. DNA methylation and atherosclerosis. J. Nutr. 132, 2406S–2409S (2002).
  CAS PubMed Google Scholar
• Sharma, P. et al. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 5, 1 (2006).
  PubMed PubMed Central Google Scholar
• Stenvinkel, P. et al. Impact of inflammation on epigenetic DNA methylation—a novel risk factor for cardiovascular disease? J. Intern. Med. 261, 488–499 (2007).
  CAS PubMed Google Scholar
• Lund, G. & Zaina, S. Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine. Curr. Opin. Lipidol. 20, 448–449 (2009).
  CAS PubMed Google Scholar
• Yideng, J. et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 26, 603–611 (2007).
  PubMed Google Scholar
• Sharma, P. et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 27, 357–365 (2008).
  CAS PubMed Google Scholar
• Lee, M. E. & Wang, H. Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc. Med. 9, 49–54 (1999).
  CAS PubMed Google Scholar
• Castro, R., Rivera, I., Blom, H. J., Jakobs, C. & Tavares de Almeida, I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 29, 3–20 (2006).
  CAS PubMed Google Scholar
• Libby, P., Okamoto, Y., Rocha, V. Z. & Folco, E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74, 213–220 (2010).
  CAS PubMed Google Scholar
• Pons, D. et al. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur. Heart J. 30, 266–277 (2009).
  CAS PubMed Google Scholar
• Goyal, B. R., Patel, M. M., Soni, M. K. & Bhadada, S. V. Therapeutic opportunities of small interfering RNA. Fundam. Clin. Pharmacol. 23, 367–386 (2009).
  CAS PubMed PubMed Central Google Scholar
• Silvestri, P. et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat. Cardiovasc. Drug Discov. 4, 109–118 (2009).
  CAS PubMed Google Scholar
• Mishra, P. J. & Bertino, J. R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10, 399–416 (2009).
  CAS PubMed Google Scholar
• Buysschaert, I., Schmidt, T., Roncal, C., Carmeliet, P. & Lambrechts, D. Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J. Cell. Mol. Med. 12, 2533–2551 (2008).
  CAS PubMed PubMed Central Google Scholar
• Esteller, M. Epigenetics in evolution and disease. Lancet 372, S90–S96 (2008).
  Google Scholar
• Waddington, C. H. Organisers and Genes (Cambridge University Press, Cambridge, 1940).
  Google Scholar
• Waddington, C. H. Canalization of development and the inheritance of acquired characters. Nature 150, 563–565 (1942).
  Google Scholar
• Holliday, R. & Pugh, J. E. DNA modification mechanisms and gene activity during development. Science 187, 226–232 (1975).
  CAS PubMed Google Scholar
• Chen, Z. X. & Riggs, A. D. Maintenance and regulation of DNA methylation patterns in mammals. Biochem. Cell Biol. 83, 438–448 (2005).
  CAS PubMed Google Scholar
• Turner, B. M. Histone acetylation as an epigenetic determinant of long-term transcriptional competence. Cell. Mol. Life Sci. 54, 21–31 (1998).
  CAS PubMed Google Scholar
• Ghildiyal, M. & Zamore, P. D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10, 94–108 (2009).
  CAS PubMed PubMed Central Google Scholar
• Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102–114 (2008).
  CAS PubMed Google Scholar
• Barringhaus, K. G. & Zamore, P. D. MicroRNAs: regulating a change of heart. Circulation 119, 2217–2224 (2009).
  PubMed PubMed Central Google Scholar
• Katey, J. et al. miR-33 coordinates genes regulating cholesterol homeostasis. Science (in press).
• Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929–930 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Skinner, M. K., Manikkam, M. & Guerrero-Bosagna, C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol. Metab. 21, 214–222 (2010).
  CAS PubMed PubMed Central Google Scholar
• Meehan, R. R. DNA methylation in animal development. Semin. Cell Dev. Biol. 14, 53–65 (2003).
  CAS PubMed Google Scholar
• Mehler, M. F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 86, 305–341 (2008).
  CAS PubMed PubMed Central Google Scholar
• Subramanian, S. & Steer, C. J. MicroRNAs as gatekeepers of apoptosis. J. Cell. Physiol. 223, 289–298 (2010).
  CAS PubMed Google Scholar
• Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171–192 (2005).
  CAS PubMed PubMed Central Google Scholar
• Krebs, J. R. The gourmet ape: evolution and human food preferences. Am. J. Clin. Nutr. 90, 707S–711S (2009).
  CAS PubMed Google Scholar
• Kelley, J. L. & Swanson, W. J. Positive selection in the human genome: from genome scans to biological significance. Annu. Rev. Genomics Hum. Genet. 9, 143–160 (2008).
  CAS PubMed Google Scholar
• Neel, J. V. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am. J. Hum. Genet. 14, 353–362 (1962).
  CAS PubMed PubMed Central Google Scholar
• Stöger, R. The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? Bioessays 30, 156–166 (2008).
  PubMed Google Scholar
• Roseboom, T., de Rooij, S. & Painter, R. The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 82, 485–491 (2006).
  PubMed Google Scholar
• Lumey, L. H. et al. Cohort profile: the Dutch Hunger Winter families study. Int. J. Epidemiol. 36, 1196–1204 (2007).
  CAS PubMed Google Scholar
• Kyle, U. G. & Pichard, C. The Dutch Famine of 1944–1945: a pathophysiological model of long-term consequences of wasting disease. Curr. Opin. Clin. Nutr. Metab. Care 9, 388–394 (2006).
  PubMed Google Scholar
• Stein, A. D. et al. Anthropometric measures in middle age after exposure to famine during gestation: evidence from the Dutch famine. Am. J. Clin. Nutr. 85, 869–876 (2007).
  CAS PubMed Google Scholar
• de Rooij, S. R., Painter, R. C., Holleman, F., Bossuyt, P. M. & Roseboom, T. J. The metabolic syndrome in adults prenatally exposed to the Dutch famine. Am. J. Clin. Nutr. 86, 1219–1224 (2007).
  CAS PubMed Google Scholar
• Dover, G. J. The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases. Trans. Am. Clin. Climatol. Assoc. 120, 199–207 (2009).
  PubMed PubMed Central Google Scholar
• Wadhwa, P. D., Buss, C., Entringer, S. & Swanson, J. M. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin. Reprod. Med. 27, 358–368 (2009).
  CAS PubMed PubMed Central Google Scholar
• Gluckman, P. D., Hanson, M. A., Cooper, C. & Thornburg, K. L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359, 61–73 (2008).
  CAS PubMed PubMed Central Google Scholar
• Waterland, R. A. & Michels, K. B. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27, 363–388 (2007).
  CAS PubMed Google Scholar
• Waterland, R. A. & Jirtle, R. L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23, 5293–5300 (2003).
  CAS PubMed PubMed Central Google Scholar
• Bogdarina, I., Welham, S., King, P. J., Burns, S. P. & Clark, A. J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 100, 520–526 (2007).
  CAS PubMed PubMed Central Google Scholar
• Heijmans, B. T. et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105, 17046–17049 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tobi, E. W. et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 18, 4046–4053 (2009).
  CAS PubMed PubMed Central Google Scholar
• El-Maarri, O. et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum. Genet. 122, 505–514 (2007).
  CAS PubMed Google Scholar
• Alkemade, F. E. et al. Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature. Am. J. Pathol. 176, 542–548 (2010).
  CAS PubMed PubMed Central Google Scholar
• van Straten, E. M. et al. The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R275–R282 (2010).
  CAS PubMed Google Scholar
• [No authors listed] Active and passive tobacco exposure: a serious pediatric health problem. A statement from the Committee on Atherosclerosis and Hypertension in Children, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 90, 2581–2590 (1994).
• Breton, C. V. et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med. 180, 462–467 (2009).
  CAS PubMed PubMed Central Google Scholar
• Xue, F. & Michels, K. B. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8, 1088–1100 (2007).
  PubMed Google Scholar
• Fraga, M. F. & Esteller, M. Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413–418 (2007).
  CAS PubMed Google Scholar
• Baccarelli, A. et al. Rapid DNA methylation changes after exposure to traffic particles. Am. J. Respir. Crit. Care Med. 179, 572–578 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hoffmann, B. et al. Residential traffic exposure and coronary heart disease: results from the Heinz Nixdorf Recall Study. Biomarkers 14 (Suppl. 1), 74–78 (2009).
  CAS PubMed Google Scholar
• Launay, J. M. et al. Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS ONE 4, e7959 (2009).
  PubMed PubMed Central Google Scholar
• Lai, C. Q. et al. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum. Genet. 125, 199–209 (2009).
  CAS PubMed Google Scholar
• Dodge, K. A. Practice and public policy in the era of gene-environment interactions. Novartis Found. Symp. 293, 87–97 (2008).
  CAS PubMed Google Scholar
• Kuzawa, C. W. & Sweet, E. Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am. J. Hum. Biol. 21, 2–15 (2009).
  PubMed Google Scholar
• Mosca, L. et al. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 96, 2468–2482 (1997).
  CAS PubMed Google Scholar
• Abbott, R. D. et al. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 3, 260–272 (1983).
  CAS PubMed Google Scholar
• Gabory, A., Attig, L. & Junien, C. Sexual dimorphism in environmental epigenetic programming. Mol. Cell. Endocrinol. 304, 8–18 (2009).
  CAS PubMed Google Scholar
• Martino, T. A. & Sole, M. J. Molecular time: an often overlooked dimension to cardiovascular disease. Circ. Res. 105, 1047–1061 (2009).
  CAS PubMed Google Scholar
• Hermida, R. C., Ayala, D. E., Fernández, J. R. & Calvo, C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51, 69–76 (2008).
  CAS PubMed Google Scholar
• Portaluppi, F. & Lemmer, B. Chronobiology and chronotherapy of ischemic heart disease. Adv. Drug Deliv. Rev. 59, 952–965 (2007).
  CAS PubMed Google Scholar
• Nakahata, Y., Grimaldi, B., Sahar, S., Hirayama, J. & Sassone-Corsi, P. Signaling to the circadian clock: plasticity by chromatin remodeling. Curr. Opin. Cell Biol. 19, 230–237 (2007).
  CAS PubMed Google Scholar
• Grimaldi, B., Nakahata, Y., Kaluzova, M., Masubuchi, S. & Sassone-Corsi, P. Chromatin remodeling, metabolism and circadian clocks: the interplay of CLOCK and SIRT1. Int. J. Biochem. Cell Biol. 41, 81–86 (2009).
  CAS PubMed Google Scholar
• Pegoraro, M. & Tauber, E. The role of microRNAs (miRNA) in circadian rhythmicity. J. Genet. 87, 505–511 (2008).
  CAS PubMed Google Scholar
• Rudic, R. D. & Fulton, D. J. Pressed for time: the circadian clock and hypertension. J. Appl. Physiol. 107, 1328–1338 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hoffman, A. E. et al. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 70, 1459–1468 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zhang, J., Burridge, K. A. & Friedman, M. H. In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis. Am. J. Physiol. Heart Circ. Physiol. 295, H1556–H1561 (2008).
  CAS PubMed PubMed Central Google Scholar
• Piekarz, R. L. et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J. Clin. Oncol. 27, 5410–5417 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lin, Y. C. et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res. 68, 2375–2383 (2008).
  CAS PubMed Google Scholar
• Mitro, N. et al. Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology 46, 885–897 (2007).
  CAS PubMed Google Scholar
• Dje N'Guessan, P. et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 380–386 (2009).
  PubMed Google Scholar
• Fang, M., Chen, D. & Yang, C. S. Dietary polyphenols may affect DNA methylation. J. Nutr. 137, 223S–228S (2007).
  CAS PubMed Google Scholar
• Gusterson, R. J., Jazrawi, E., Adcock, I. M. & Latchman, D. S. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J. Biol. Chem. 278, 6838–6847 (2003).
  CAS PubMed Google Scholar
• Balasubramanyam, K. et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163–51171 (2004).
  CAS PubMed Google Scholar
• Morimoto, T. et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118, 868–878 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dhillon, N. et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14, 4491–4499 (2008).
  CAS PubMed Google Scholar
• Chen, W., Bacanamwo, M. & Harrison, D. G. Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription. J. Biol. Chem. 283, 16293–16298 (2008).
  CAS PubMed PubMed Central Google Scholar
• Choi, K. C. et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 69, 583–592 (2009).
  CAS PubMed Google Scholar
• Balasubramanyam, K. et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279, 33716–33726 (2004).
  CAS PubMed Google Scholar
• Wang, B. et al. Phosphorylation and acetylation of histone H3 and autoregulation by early growth response 1 mediate interleukin 1beta induction of early growth response 1 transcription. Arterioscler. Thromb. Vasc. Biol. 30, 536–545 (2010).
  CAS PubMed Google Scholar
• Shin, I. S. et al. Early growth response factor-1 is associated with intraluminal thrombus formation in human abdominal aortic aneurysm. J. Am. Coll. Cardiol. 53, 792–799 (2009).
  PubMed Google Scholar
• Abdel-Malak, N. A., Mofarrahi, M., Mayaki, D., Khachigian, L. M. & Hussain, S. N. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Arterioscler. Thromb. Vasc. Biol. 29, 209–216 (2009).
  CAS PubMed Google Scholar
• Oka, D. et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 115, 3412–3426 (2009).
  CAS PubMed Google Scholar
• Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).
  CAS PubMed PubMed Central Google Scholar
• Slatkin, M. Epigenetic inheritance and the missing heritability problem. Genetics 182, 845–850 (2009).
  PubMed PubMed Central Google Scholar
• [No authors listed] Moving AHEAD with an international human epigenome project. Nature 454, 711–715 (2008).